Literature DB >> 29224842

M13 bacteriophage purification using poly(ionic liquids) as alternative separation matrices.

Maria João Jacinto1, David J S Patinha2, Isabel M Marrucho3, João Gonçalves4, Richard C Willson5, Ana M Azevedo6, M Raquel Aires-Barros1.   

Abstract

M13 is a filamentous, non-lytic bacteriophage that infects Escherichia coli via the F pilus. Currently, phage M13 is widely used in phage display technology and bio-nanotechnology, and is considered a possible antibacterial therapeutic agent, among other applications. Conventional phage purification involves 5-7 operational steps, with high operational costs and significant product loss (approximately 60%). In this work, we propose a scalable purification process for M13 bacteriophage using a novel stationary phase based on a polymeric ionic liquid (PIL) with a positively charged backbone structure. Poly (1-vinyl-3-ethyl imidazolium bis(trifluoromethylsulfonyl) imide) - poly(VEIM-TFSI) predominantly acted as an anion exchanger under binding-elution mode. This revealed to be a rapid and simple method for the recovery of phage M13 with an overall separation yield of over 70% after a single downstream step. To the best of our knowledge, PILs have never been used as separation matrices for biological products and the results obtained, together with the large number of cations and anions available to prepare PILs, illustrate well the large potential of the proposed methodology.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Anion exchange; Batch adsorption; Downstream processing; M13 bacteriophage; Poly(ionic liquids)

Mesh:

Substances:

Year:  2017        PMID: 29224842     DOI: 10.1016/j.chroma.2017.12.005

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  1 in total

1.  The conversion of α-pinene to cis-pinane using a nickel catalyst supported on a discarded fluid catalytic cracking catalyst with an ionic liquid layer.

Authors:  Shunyou Hu; Linlin Wang; Xiaopeng Chen; Xiaojie Wei; Zhangfa Tong; Lijiang Yin
Journal:  RSC Adv       Date:  2019-02-18       Impact factor: 3.361

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.